Effects of statin use on length of hospital stay and clinical outcome in hospitalized COVID-19 patients: A retrospective cohort study
The search for effective COVID-19 management strategies con tinues to evolve. Severity of COVID-19 has been reported to be positively correlated with a concomitant rise in inflammatory cytokine levels (1, 2). Statins (3-hydroxy-3-methylglutaryl co enzyme A (HMG-CoA) reductase inhibitors) are widely used for dyslipidemia for primary and secondary prevention of cardiac and cerebrovascular events. Statins […]